This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (41)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Mark S. Horwich, MD; W. King Engel, MD; Priscilla B. Chauvin

Arch Neurol. 1974;30(4):332-333.

Abstract
Sera from patients with amyotrophic lateral sclerosis (ALS) were applied to mouse anterior horn cells in tissue culture. No unique toxic effect was observed when compared with sera from normal and non-ALS neuromuscular disease subjects.

Author Affiliations
Bethesda, Md

From the Medical Neurology Branch, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Public Health Service, Department of Health, Education, and Welfare, Bethesda, Md.

Footnotes
Accepted for publication Dec 12, 1973.

Reprint requests to Medical Neurology Branch, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, MD 20014 (Dr. Horwich).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Double-blind Study of the Effectiveness of Cyclosporine in Amyotrophic Lateral Sclerosis
Appel et al.
Arch Neurol 1988;45:381-386.
ABSTRACT  

Amyotrophic Lateral Sclerosis: Recent Advances in Pathogenesis and Therapeutic Trials
Mitsumoto et al.
Arch Neurol 1988;45:189-202.
ABSTRACT  

Amyotrophic Lateral Sclerosis: Associated Clinical Disorders and Immunological Evaluations
Appel et al.
Arch Neurol 1986;43:234-238.
ABSTRACT  

Passive Transfer Experiments in Amyotrophic Lateral Sclerosis
Denys et al.
Arch Neurol 1984;41:161-163.
ABSTRACT  

Plasmapheresis With Immunosuppression in Amyotrophic Lateral Sclerosis
Kelemen et al.
Arch Neurol 1983;40:752-753.
ABSTRACT